Gene therapy with angiogenic factors: a new potential approach to the treatment of ischemic diseases.
Safi
J
J
Gene Therapy Unit, Laboratory of Cardiovascular Science, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA.
Gloe
T R
TR
Riccioni
T
T
Kovesdi
I
I
Capogrossi
M C
MC
D000818:Animals; D016228:Endothelial Growth Factors / Q000494:pharmacology / Q000502:physiology; D016222:Fibroblast Growth Factor 2 / Q000494:pharmacology / Q000502:physiology; D051521:Fibroblast Growth Factor 5; D005346:Fibroblast Growth Factors / Q000235:genetics / Q000494:pharmacology / Q000502:physiology*; D005544:Forecasting; D018014:Gene Transfer Techniques; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors / Q000235:genetics*; D006493:Heparin / Q000494:pharmacology / Q000502:physiology; D006801:Humans; D007511:Ischemia / Q000628:therapy*; D008222:Lymphokines / Q000494:pharmacology / Q000502:physiology; D009389:Neovascularization, Pathologic / Q000503:physiopathology; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D016228:Endothelial Growth Factors; C496449:FGF5 protein, human; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D016222:Fibroblast Growth Factor 2; D051521:Fibroblast Growth Factor 5; D005346:Fibroblast Growth Factors; D006493:Heparin